{"database": "lobbying", "table": "lobbying_activities", "rows": [[2814412, "540a8aed-28ad-4f99-a8b4-342165c8efe9", "Q2", "OLSSON, FRANK, WEEDA, TERMAN & MATZ, PC", 30212, "JAZZ PHARMACEUTICALS INC.", 2022, "second_quarter", "BUD", "Appropriations issues, FDA and DEA issues", "Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE", 20000, null, 0, 0, "2022-07-05T13:23:00-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["2814412"], "units": {}, "query_ms": 10.78835700172931, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}